Rotigotine
Back to searchMolecule Structure
Scientific Name
Rotigotine
Description of the Drug
Rotigotine is a non-selective dopamine agonist used for the treatment of Parkinson’s Disease and Restless Leg Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05271
http://www.drugbank.ca/drugs/DB05271
Brand Name(s)
Neupro
Company Owner(s)
Ucb Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1088585 | |
PharmGKB | PA166165149 | |
DrugBank | DB05271 | |
PubChem: Thomson Pharma | 14752454 | 14752455 |
PubChem | 59227 | |
LINCS | LSM-45883 | |
Nikkaji | J285.097D | |
BindingDB | 50123626 | |
EPA CompTox Dashboard | DTXSID5046772 | |
DrugCentral | 2407 | |
Brenda | 256261 | |
ChemicalBook | CB81001679 | |
Guide to Pharmacology | 941 | |
rxnorm | ROTIGOTINE | NEUPRO |
PubChem: Drugs of the Future | 12014593 | |
ChEBI | 135351 | |
ZINC | ZINC000000004028 |